SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The sharp rally has no confirmed company-news catalyst; traders are focused on anticipation of the REGAL Phase 3 final analysis, which is triggered at 80 survival events after the last disclosed count of 78. Some interpret the CEOs anniversary message and SELLASs planned ASH presence as signs of a potential buyout, while others call that speculation and see the move as a rebound or possible short covering.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the dominant focus, with traders watching guidance, subscriber engagement and advertising growth amid concerns about competition and a prolonged share-price decline. Many expect further weakness, while bulls argue pessimism is already priced in and see room for a rebound if results or the outlook are stronger than feared.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is drawing attention as traders position around the full Phase 3 melanoma results for its personalized cancer vaccine, intismeran, with Merck; the prior positive topline result has fueled a sharp rally. Bulls see validation of a broader oncology platform, while skeptics warn that expectations and valuation are stretched and debate a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is being attributed by traders to possible short covering and anticipation of upcoming DM1 and FSHD siRNA data, with Arrowheads RNAi results cited as supportive context. No new Sarepta catalyst is confirmed in the discussion, and some traders view the move as technical or part of broader biotech strength.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs steep selloff is being discussed amid broader neocloud concerns about financing, AI infrastructure spending returns, and whether providers can remain independent; traders also point to dilution and possible project delays. The community is split between bearish views that the weakness may persist and bullish arguments that IRENs cash-funded data centers and customer prepayments distinguish it from more debt-heavy peers.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new share-repurchase authorization are being overshadowed by a narrowed full-year profit outlook whose midpoint was unchanged, prompting a sharp selloff. Traders are split between viewing the buyback and stronger cash-flow outlook as support and seeing cautious guidance, lower U.S. sales, and cost pressures as reasons for the decline.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solanas volatile pullback and bounce amid broader crypto weakness are driving discussion, with traders watching support and Bitcoins direction. Dip-buyers are accumulating and staking, while bearish traders warn the recovery may fail and expect further downside.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA is drawing attention as it approaches and tests its 200-day moving average ahead of earnings, with traders watching for stronger volume and sustained momentum. Optimism about ASCENIV growth and share repurchases is tempered by calls for earnings to validate the outlook and lingering concerns over BIVIGAM weakness and management credibility.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash transaction as a potential balance-sheet and strategic reset. Bulls welcome the deal and momentum, while skeptics argue the sale removes a revenue-generating business and leaves concerns about declining operations and debt; the transaction remains subject to approval.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is drawing attention after a sharp post-earnings selloff despite beating expectations, as investors focused on slower U.S. da Vinci procedure growth and a cautious outlook. Traders are split between viewing the decline as an overreaction given the companys robotic-surgery position and recurring revenue, and seeing valuation, competition, and growth uncertainty as reasons for a reset.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cathie Wood-Led Ark Invest's Biggest Q3 Winners And Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged

Equity

Ark's latest quarterly report shows that several stocks made meaningful contributions across multiple ETFs.

Cathie Wood's ARK Scoops Up Over 32,000 Meta Shares In 2 Days — Wall Street’s Split Over AI Spending

ARK's latest purchases come as Meta's new Muse AI models draw bullish analyst calls, even as concerns grow over the company's spending plans ahead of earnings.

Wall Street Split On Robinhood Ahead Of Earnings – Wells Fargo Cuts HOOD, BLSH Targets

Robinhood is scheduled to announce its third-quarter results on October 27, and analysts are expecting sales of $1.4 billion and earnings per share of $0.64, according to Koyfin.


PLTR Stock Rally Intact After Best Quarter In A Year — Retail Watches Cautiously As Palantir Adds Data Center Partner 

Palantir has partnered with Armada to expand its sovereign AI strategy from software into physical computing infrastructure.


TOST Stock Gets A DoorDash AI Test: Jefferies Breaks Down Where DashOS Could Pressure Toast 

Jefferies said Toast’s POS leadership remains strong, while DashOS could pressure Toast’s marketing and customer analytics software sales. 


Crypto's Next Catalyst Could Be Tokenized Stocks: Clear Street Raises Bullish, Coinbase Targets

Clear Street raised price target for crypto exchange Bullish, citing that the setback in CLARITY Act could lead to adoption of tokenized stocks. 

Cathie Wood's ARK Invest Adds Nvidia Stake, Sells AMD Stock Across Four ETFs

The transactions extend a recent pattern of ARK increasing its exposure to Nvidia while selectively reducing its AMD holdings.


SHOP Stock Heads For Best Week In A Year: Jefferies Says Shopify 'Cleared A High Bar' After Solid Q2 

Wall Street firms have raised their price targets on Shopify following its fiscal second-quarter earnings.  


Palantir’s AI Rally Leaves Burry Wishing He’d Shorted $1 Trillion, Cathie Wood’s ARK Trims Holdings

Cathie Wood’s ARK Invest sold 39,233 Palantir shares across ARKK and ARKF, worth $6.38 million at Tuesday’s close.

ETFs to Watch as HOOD Sinks Despite Q2 Earnings Beat, Better Cash Position

HOOD slides after a Q2 earnings beat as crypto revenues weaken, but stronger cash and trading metrics put ETFs with Robinhood exposure in focus.

ARK ETF Trust - ARK Blockchain & Fintech Innovation ETF

Neutral Sentiment

<ul class="summary-bullets"><li>10x Genomics and Palantir were among the standout winners across Ark's portfolios.</li><li>Ark attributed the 10x Genomics rally to growing interest in single-cell sequencing and spatial analysis as sources of data for AI drug-discovery models.</li><li>Nvidia also made the cut, particularly across Ark's technology-focused portfolios.</li></ul>Cathie Wood-led Ark Invest's portfolios saw some dramatic winners and losers in the third quarter (Q3), with artificial intelligence, biotech, crypto and other disruptive-technology bets among the biggest drivers.Ark's latest quarterly report shows that several stocks made meaningful contributions across multiple ETFs, while Tesla Inc. (TSLA) and Rocket Lab Corp. (RKLB) emerged among the most notable drags. Ark's attribution figures measure each holding's contribution to its ETF's performance, rather than the stock's standalone return.<h2 class="st-heading-2">Ark’s Biggest Winners In Q3</h2>10x Genomics Inc. (TXG) was the standout winner across Ark's portfolios. The stock contributed 9.03 percentage points to ARK Genomic Revolution ETF’s (ARKG) 28.92% Q3 gain and 2.92 points to ARK Innovation ETF’s (ARKK) 10.39% return during the quarter.Ark attributed the rally to growing interest in single-cell sequencing and spatial analysis as sources of data for AI drug-discovery models. The firm also highlighted the launch of 10x's Atera spatial system, with orders already in place for the 40 shipments anticipated in 2026.Twist Bioscience Corp. (TWST) was another major biotech winner, contributing 6.51 points to ARKG and 2.55 points to ARKK. The stock jumped 87.83% during the quarter. Ark said Twist was increasingly recognized as a beneficiary of AI-driven drug discovery, including through its protein-characterization work for Anthropic.&nbsp;Tempus AI Inc. (TEM) also stood out, contributing 3.21 points to ARKG and 2.08 points to ARKK, while gaining 41.38% during the quarter.&nbsp;Then there was Palantir Technologies Inc. (PLTR), emerging as one of the most important cross-ETF winners. Palantir contributed 1.86 points to ARK Autonomous Technology &amp; Robotics ETF (ARKQ), 1.62 points to ARKK, 1.48 points to ARK Next Generation Technology ETF (ARKW), 2.39 points to ARK Blockchain &amp; Fintech Innovation ETF (ARKF) and 1.47 points to ARK Space &amp; Defense Innovation ETF (ARKX).Nvidia Corp. (NVDA) also made the cut, particularly across Ark's technology-focused portfolios. It contributed 0.49 points to ARKQ and 0.48 points to ARKX.<h2 class="st-heading-2">Biggest Losers</h2>Tesla was the clearest recurring drag across Ark's portfolios. It was the biggest detractor in ARKQ (-1.72 percentage points), ARKK (-1.75 points) and ARKW (-1.43 points).Ark said Tesla sold off sharply after its second-quarter (Q2) results disappointed on profitability, with price cuts and the wind-down of the Model S and Model X pressuring margins.But the firm also pointed to a recovery in the stock as Tesla publicly launched Cybercab in Austin and surpassed 1 million unsupervised robotaxi miles, up from 380,000 just six weeks earlier.Rocket Lab was another major drag, particularly in the space-focused portfolios. It contributed -1.39 points to ARKQ and -2.04 points to ARKX.The firm noted that Rocket Lab completed 21 flights in 2025 and had a backlog of more than 90 missions as of the second quarter.Ark's biggest winners included AI, AI-enabled biotech and other technology bets, while some of its highest-profile holdings, most notably Tesla and Rocket Lab, weighed on performance.<a href="https://stocktwits.com/symbol/ARKK">ARKK ETF</a> declined nearly 5% in Friday’s regular trading session and fell nearly 0.4% during the after-hours trade. Retail sentiment on Stocktwits around ARKK trended in the ‘bearish’ territory at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-denies-spacex-starlink-slowed-down-white-house-elon-musk/cZxkR3ARBtB">Trump Denies SpaceX’s Starlink Was Slowed Down Over Ukraine By Either White House Or Elon Musk: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cathie Wood, chief executive officer and chief investment officer, Ark Invest, gestures as she speaks during the Bitcoin 2022 Conference at Miami Beach Convention Center on April 7, 2022. (Photo by Marco Bello/Getty Images)

Cathie Wood-Led Ark Invest's Biggest Q3 Winners and Losers — PLTR, NVDA, TXG Led While TSLA, RKLB Dragged

ARK Fintech Innovation ETF

ARK Investment Management LLC - ARK Genomic Revolution ETF

ARK Innovation ETF

ARK Next Generation Internet ETF

ARK Space Exploration & Innovation ETF

Palantir Technologies Inc

Rocket Lab USA Inc

Tempus AI Inc

Twist Bioscience Corp

10x Genomics Inc - Ordinary Shares - Class A

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Feed

News

Sentiment

Fundamentals

Info

ARKF ARK Fintech Innovation ETF

Fundamentals

Latest ARKF News